The goal of this study was to determine whether both gonadotropin-releasing
hormone (GnRH) agonists and antagonists could enhance fertility in rats gi
ven sterilizing doses of irradiation, to quantify the levels of fertility,
and to measure their relative effectiveness in stimulating recovery of sper
matogenesis. Irradiated rats were treated with either the GnRH agonist Lupr
on or the GnRH antagonist Cetrorelix, which have different mechanisms of ac
tion. The antagonist suppressed luteinizing hormone (LH), reducing intrates
ticular testosterone from 75 ng/g-testis to about 5 ng/g-testis, whereas th
e agonist reduced intratesticular testosterone only moderately to about 20
ng/g-testis, presumably by direct action on the Leydig cell since LH was el
evated. These differences were reflected in Leydig cell morphology. When ho
rmone treatment was started immediately after 3.7-Gy irradiation, fertility
was normal at week 20 in the agonist-treated rats and was near normal in a
ntagonist-treated rats, whereas irradiated-only rats were sterile. At week
22 in the GnRH antagonist-treated rats, testicular weights and sperm counts
were maintained at greater than 80% of control values; in GnRH agonist-tre
ated rats, they were slightly but significantly lower than in GnRH antagoni
st-treated rats, and in irradiated-only rats, they were very low. When the
treatment was initiated 10 weeks after 5-Gy irradiation, after spermatogene
sis had ceased, fertility was restored at week 30 to subnormal levels in 83
% of GnRH agonist- and 50% of GnRH antagonist-treated rats. Testis weights
and sperm counts were restored to about 50% and 20% of control levels, resp
ectively. The percentages of tubules with differentiated germ cells were hi
gher in all groups of antagonist-treated rats than in those of agonist-trea
ted rats. Thus, both GnRH agonists and antagonists produced dramatic recove
ry of spermatogenesis and fertility in irradiated rats, although there were
differences in mechanism and perhaps also in effectiveness.